Zobrazeno 1 - 10 of 70 pro vyhledávání: '"You Jian He"'
1
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
Autor: Yu Hong Li, Pei Rong Ding, You Jian He, Yan Xia Shi, Zhi Qiang Wang, Wen Qi Jiang, Xin An, Feng Hua Wang, Rui-Hua Xu
Publikováno v: Biomarkers. 15:516-522
Background: Elevated neutrophil to lymphocyte ratio (NLR) is linked with worse survival in many malignancies, whereas its association with pancreatic cancer (PC) remains unclear.Methods: We retrospectively reviewed 95 patients with locally advanced o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f2f2fdf6a59c0b04535e654e3f0940f
https://doi.org/10.3109/1354750x.2010.491557
Zobrazit plný text záznamu
2
Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer
Autor: Yan Xia Shi, Miao Zhen Qiu, Xiao Juan Xiang, Xiao Qing Chen, Zhi Qiang Wang, Yu Hong Li, Hui Yan Luo, Rui-Hua Xu, Feng Hua Wang, You Jian He
Publikováno v: Journal of Cancer Research and Clinical Oncology. 136:503-510
The aim of this study is to evaluate the safety and efficacy of the combination of capecitabine and oxaliplatin (XELOX) as first-line treatment in Chinese patients with metastatic colorectal carcinoma (mCRC). Furthermore, we aimed to explore whether
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6875d68fcf76b10f92d01719ee2b47
https://doi.org/10.1007/s00432-009-0682-5
Zobrazit plný text záznamu
3
Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma
Autor: Wen Qi Jiang, Yan Ming Deng, Yan Chen, De Ming Xu, Guo Qing Hu, You Jian He, Xiao Juan Xiang, Yu Hong Li, Feng Hua Wang, Qing Lin
Publikováno v: Cancer Chemotherapy and Pharmacology. 62:539-544
Cisplatin combined with 5-fluorouracil (5-Fu) is widely used in the management of advanced nasopharyngeal carcinoma (NPC). However, catheters and pumps are necessary for the continuous infusion of 5-Fu, which add to the cost, immobility and inconveni
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c192898b3b2f2e55b6f07cc27b70b12b
https://doi.org/10.1007/s00280-007-0641-2
Zobrazit plný text záznamu
4
The prediction of recurrence and survival of patients with Dukes’ B colorectal cancer after curative resection with immunohistochemical detection of Survivin and Livin expressions
Autor: Wen-Jing He, Jun-He Li, You-Jian He
Publikováno v: The Chinese-German Journal of Clinical Oncology. 7:22-26
To detect the expressions of Survivin and Livin in Dukes’ B colorectal cancer tissues and analyze the prognosis after curative resection. The expressions of Survivin and Livin were evaluated immunohistochemically in Dukes’ B colorectal cancer spe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4419f295ddb3da9f15a3009ce9db5215
https://doi.org/10.1007/s10330-007-0136-y
Zobrazit plný text záznamu
5
Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol
Autor: Xiaofei Sun, Zhi Hui Wang, Yi Xia, Jia Yu Lin, Dong Gen Lui, You Jian He, Zi Jun Zhen, Zhong Zhen Guan
Publikováno v: European Journal of Haematology. 77:365-371
Objectives: This study was designed to evaluate the efficacy and toxicity of the modified B-Non-Hodgkin's Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90-based protocol in Chinese children and adolescents with Burkitt's lymphoma and large cell lymph
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97ae6d53d36ca881bae06a654aba351e
https://doi.org/10.1111/j.1600-0609.2006.00735.x
Zobrazit plný text záznamu
6
Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma
Autor: Wen Qi Jiang, Zhong Zhen Guan, Li Zhang, Tong Yu Lin, Fen Hua Wang, Yi Fu He, Zhong Jun Xia, Hui Qiang Huang, You Jian He, Xu Bin Lin, Yu Hong Li, Xiaofei Sun
Publikováno v: Cancer. 106:1320-1325
BACKGROUND Hepatitis B virus (HBV) infection is a common disease in China. Severe hepatitis is a well recognized complication in HBV carriers with malignant disease who receive cytotoxic chemotherapy. The objective of the current study was to assess
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7731b93df2bf38e75e58212a1e39a70e
https://doi.org/10.1002/cncr.21701
Zobrazit plný text záznamu
8
The preliminary results of treatment ofadvanced and recurrent malignant lymphoma by beac regimen supported with autologous hematopoietic stem cells transplantation
Autor: Tong Yu Lin, Dong Geng Liu, Zhong Zhen Guan, Yu Hong Li, Zhong Mei Zhou, Hui Qiang Huang, You Jian He, Li Zhang, Rui Hua Xu, Wen Qi Jiang, Xiao Fei Sun
Publikováno v: Chinese Journal of Cancer Research. 14:50-53
Objective: High dose chemotherapy supported by autologous hematopoietic stem cells transplantation (AHSCT) has developed dramaticly in recent years and become the most effective approach to improve radical treatment for the chemo-sensitive lymphoma.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8d7931d6229d98da41165f9758323975
https://doi.org/10.1007/s11670-002-0011-x
Zobrazit plný text záznamu
9
Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer
Autor: Gong Chen, Pei-Rong Ding, Zhi Qiang Wang, Zhenhai Lu, Rui-Hua Xu, Huiyan Luo, Cong Li, Ming Zhao, Xiaojun Wu, Yu Hong Li, Cui Chen, Yunfei Yuan, Desen Wan, Yangkui Gu, Zhizhong Pan, Fenghua Wang, Wang Li, You-Jian He
Publikováno v: Cancer chemotherapy and pharmacology. 74(5)
To determine the maximum tolerated dose (MTD) and preliminary efficacy of concurrent hepatic arterial infusion (HAI) of floxuridine (FUDR) and systemic modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresecta
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78f77a2f13c62a9e6cdf5415d9e360dd
https://pubmed.ncbi.nlm.nih.gov/25217393
Zobrazit plný text záznamu
10
Comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea, and anorexia: a single-blind, randomized, crossover study
Autor: Gang Cheng, Feng Yi Feng, Mei Zhen Zhou, Yu Hong Li, Minoru Yamamoto, You Jian He, Pin Zhang
Publikováno v: Current Therapeutic Research. 61:901-909
Background: Ramosetron, a new specific 5-hydroxytryptamine 3 (5HT 3 )-receptor antagonist, is 58 times more potent than granisetron, and its antiemetic effect lasts 10.7 times longer than that of granisetron in ferrets treated with cisplatin. Objecti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c392162765e3d526c64abb4ec8d29124
https://doi.org/10.1016/s0011-393x(00)90017-1
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje